FMR1 and fragile X syndrome: Furthermore, it highlighted the distinction between FXS hESCs and iPSCs in disease modeling, by drawing attention to the limitations involved in using mutant iPSCs when investigating the mechanism underlying epigenetic gene silencing of FMR1.